Literature DB >> 9504309

Chondrosarcomas of the skull base: review of the literature and report of two cases.

A D Rapidis1, G Archondakis, D Anteriotis, C A Skouteris.   

Abstract

Chondrosarcomas are malignant mesenchymal tumours occurring only rarely in the bones of the cranium. Less than 5% of all chondrosarcomas are located in the head and neck area and their commonest location is the ethmoids and the sphenoid sinus. They are slow-growing tumours with low malignancy rate and unclear histopathogenesis. The prevailing hypothesis is that they arise from cartilaginous remnants in the petro-clival, spheno-occipital and fronto-nasal synchondroses. Diagnosis is only made after biopsy since clinical signs and symptoms and radiological findings are not pathognomonic. Symptomatology mainly derives from tumour encroachment and infiltration of adjacent intracranial structures. Surgery is the treatment of choice, while radiotherapy has an adjunctive role. Chemotherapy is not effective. Partial tumour excision to alleviate symptoms is an acceptable surgical technique since diagnosis is usually late, but treatment can be repeated when recurrence occurs. During the last year, two cases of chondrosarcoma of the skull base were treated in our institution. Both patients were female, aged 62 and 73, respectively. Computerized Tomography and Magnetic Resonance Imaging were inconclusive and diagnosis was established after biopsy. Treatment for both cases was surgical, with partial excision due to intracranial involvement of the internal carotid artery. In one case, a temporal approach was used, whereas the other patient was operated on via a naso-orbital approach. One patient received postoperative radiotherapy. The postoperative course was uneventful in both patients and marked clinical improvement was noted 18 months and 1 year after surgery. We support the view that partial resection of chondrosarcomas of the base of the skull to alleviate symptoms is an acceptable surgical treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9504309     DOI: 10.1016/s1010-5182(97)80034-0

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  10 in total

1.  Two rare cases of craniofacial chondrosarcoma.

Authors:  Pankaj Gupta; Ashu Seith Bhalla; Venkat Karthikeyan; Ongkila Bhutia
Journal:  World J Radiol       Date:  2012-06-28

2.  Successful treatment of a chemoresistant tumor with temozolomide in an adult patient: report of a recurrent intracranial mesenchymal chondrosarcoma.

Authors:  Sercan Aksoy; Huseyin Abali; Saadettin Kiliçkap; Nilüfer Güler
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

Review 3.  [Infratentorial tumors].

Authors:  I Q Grunwald; C Veith; M Backens; C Roth; P Papanagiotou; W Reith
Journal:  Radiologe       Date:  2007-06       Impact factor: 0.635

4.  Cranial chondrosarcoma and recurrence.

Authors:  Orin G Bloch; Brian J Jian; Isaac Yang; Seunggu J Han; Derick Aranda; Brian J Ahn; Andrew T Parsa
Journal:  Skull Base       Date:  2010-05

5.  Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull base.

Authors:  Hiroshi Fuji; Yoko Nakasu; Yuji Ishida; Satoshi Horiguchi; Koichi Mitsuya; Hiroya Kashiwagi; Shigeyuki Murayama
Journal:  Skull Base       Date:  2011-05

6.  Conventional and perfusion MR imaging of parafalcine chondrosarcoma.

Authors:  Nishita Kothary; Meng Law; Soonmee Cha; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

Review 7.  Postsurgical management strategies in patients with skull base chondrosarcomas.

Authors:  Aditya Iyer; Hideyuki Kano; Douglas Kondziolka; Xiaomin Liu; John C Flickinger; L Dade Lunsford
Journal:  CNS Oncol       Date:  2013-03

Review 8.  Solitary nonchordomatous lesions of the clival bone: differential diagnosis and current therapeutic strategies.

Authors:  Filippo Gagliardi; Nicola Boari; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2013-04-06       Impact factor: 3.042

Review 9.  A systematic review of intracranial chondrosarcoma and survival.

Authors:  Orin G Bloch; Brian J Jian; Isaac Yang; Seunggu J Han; Derick Aranda; Brian J Ahn; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-09-30       Impact factor: 1.961

10.  Treatment, outcomes, and demographics in sinonasal sarcoma: a systematic review of the literature.

Authors:  Mitchell R Gore
Journal:  BMC Ear Nose Throat Disord       Date:  2018-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.